Reversal of nephrotic syndrome due to AA amyloidosis in psoriatic patients on long-term colchicine treatment

Nephron

Volumn 82, Issue 4, 1999, Pages 348-353

  Kagan, Alexander ^a,b   Husza'r, Monica ^a   Frumkin, Azriel ^a   Rapoport, Jayson ^a  

^a KAPLAN MEDICAL CENTER   (Israel)

^b KAPLAN HOSPITAL   (Israel)

Author keywords

Amyloidosis; Colchicine; Erythrodermic psoriasis; Kidney biopsy; Nephrotic syndrome; Psoriatic arthropathy

Indexed keywords

AMYLOID A PROTEIN; COLCHICINE;

ADULT; AMYLOIDOSIS; ARTICLE; CASE REPORT; DISEASE COURSE; FEMALE; HUMAN; LONG TERM CARE; NEPHROTIC SYNDROME; PRIORITY JOURNAL; PSORIASIS; PSORIATIC ARTHRITIS; REMISSION;

ADULT; AMYLOIDOSIS; ARTHRITIS, PSORIATIC; COLCHICINE; DERMATITIS, EXFOLIATIVE; FEMALE; HUMANS; NEPHROTIC SYNDROME; TIME; TREATMENT OUTCOME;

EID: 0032839186     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: 10.1159/000045450     Document Type: Article

References (53)

1. Madeddu P, Ena P, Glorioso N, Cerimele D, Rapelli A: High prevalence of microproteinuria, an early index of renal impairment, in patients with diffuse psoriasis. Nephron 1988; 48:222-225.
2. Grcevska L, Polenakovic M, Ferluga D, Vizjak A, Stavric G: Membranous nephropathy with severe tubulointerstitial and vascular changes in a patient with psoriatic arthritis treated with non-steroidal anti-inflammatory drugs. Clin Nephrol 1993;39:250-253.
3. Sakemi T, Hayashida R, Ikeda Y, Baba N, Nishihara G, Kohda H: Membranous glomerulonephropathy associated with psoriasis vulgaris. Nephron 1996;72:351-352.
4. Krothapalli R, Neeland B, Small S, Duffy WB, Gyorkey F, Senekjian HO: IgA nephropathy in a patient with ankylosing spondylitis and a solitary kidney. Clin Nephrol 1984;21:134-137.
5. Imai H, Kodama T, Ishino T, Yasuda T, Miura AB, Asakura K, Nishimura S, Nakamoto Y: IgA nephropathy associated with hyper-Ig-Anemia, psoriasis or pustulosis and ossification. Clin Nephrol 1995;44:64-68.
6. Moise R, Asch L, Limbs JL: Rhumatisme psoriasique et amylose. Strasbourg Méd 1965;16: 245-253.
7. Reed WB, Wright V: Psoriatic arthritis; in Hill AGS (ed): Modern Trends in Rheumatology. London, Butterworth, 1966, pp 375-383.
8. Ferguson A, Downie WW: Gastrointestinal amyloidosis in psoriatic arthritis. Ann Rheum Dis 1968;27:245-248.
9. Berger PA: Amyloidosis - A complication of pustular psoriasis. Br Med J 1969;ii:351-353.
10. Brownstein MH, Helwig EB: Systemic amyloidosis complicating dermatoses. Arch Dermatol 1970;102:1-7.
11. Mackie RM, Burton J: Pustular psoriasis in association with renal amyloidosis. Br J Dermatol 1974;90:567-571.
12. Lambert JR, Ansell BM, Stephenson E, Wright V: Psoriatic arthritis in childhood. Clin Rheum Dis 1976;2:339-352.
13. Qureshi MSA, Sandle GI: Amyloidosis complicating psoriatic arthritis. Br Med J 1977;ii: 302.
14. Friedman R, Agus B, Ames E: Amyloid arthropathy in a patient with psoriasis and amyloidosis. Arthritis Rheum 1981;24:1320-1323.
15. Willoughby CP, Bennett MK, Banerji A, Jewell DP: Gastrointestinal amyloidosis complicating psoriatic arthropathy. Postgrad Med J 1981;57: 663-667.
16. Taylor R, Morgan JM, Davie RM: Renal amyloidosis secondary to psoriatic arthropathy. Br J Clin Pract 1981;35:410-411, 414.
17. Amir-Ansari B, Joekes AM, Parkinson MC: Amyloidosis complicating psoriasis. Postgrad Med J 1982;58:364-366.
18. David M, Abraham D, Weinberger A, Feuerman EJ: Generalised pustular psoriasis, psoriatic arthritis and nephrotic syndrome associated with systemic amyloidosis. Dermatologica 1982;165:168-171.
19. Canuel C, Krulik M, Mougeot-Martin M, Laplanche A, Gintzburger S, Genot JY, Audebert AA, Debray J: Rhumatisme psoriasique et amylose rénale. A propos d'un cas. Revue de la littérature. Semaine Hôp 1982;58:523-528.
20. Sharma SC, Mortimer G, Kennedy S, Thomson J: Secondary amyloidosis affecting the skin in arthropathic psoriasis. Br J Dermatol 1983; 108:205-210.
21. Bruet A, Abel L, Hillion D, Fendler JP: Pelvispondylite psoriasique compliquée d'amylose rénale. Press Méd 1983;12:2768.
22. Pattin S, Giudicelli CP, Nedelec G, Eulry F, Doury P: Amylose rénale d'évolution prolongée et rhumatisme psoriasique. Rev Rheum 1985;52:259-262.
23. Ekenstam E, Michaelsson G, Hallgren R: Response of secondary amyloidosis in psoriasis to treatment with etretinate and ultraviolet light. Br Med J 1986;293:733-734.
24. Atanasova P, Dimitrova D, Milkov V: A patient with psoriatic arthritis and secondary amyloidosis (in Bulgarian). Vutr Boles 1989; 28:79-89.
25. Gertz MA, Kyle RA: Secondary amyloidosis: Response and survival. Medicine 1991;70: 246-256.
26. Roth PE, Grosshans E, Bergoend H: Psoriasis: Evolution et complications mortelles. Ann Dermatol Vénéréol 1991;118:97-105.
27. Fak AS, Ozener C, Akoglu E: Colchicine and secondary amyloidosis. Ann Intern Med 1992; 117:795.
28. Gaikwad S, Hakim AS, Paidhunghat JV, Krishankumari K: Amyloidosis - A rare complication of psoriasis. J Assoc Physicians India 1994;42:639-640.
29. Wittenberg GP, Oursler JR, Peters MS: Secondary amyloidosis complicating psoriasis. J Am Acad Dermatol 1995;32:465-468.
30. Stey C, Marincek B, Salomon F: Amyloidstruma. Dtsch Med Wochenschr 1995;120:874-878.
31. Ahmed A, Chung-Park M, Mustafa K, Khan MA: Psoriatic spondyloarthropathy with secondary amyloidosis. J Rheumatol 1996;23: 1107-1110.
32. Tsuda S, Maeyama Y, Yamamoto N, Sasai Y, Yoshida K: Secondary amyloidosis complicating arthropathic psoriasis. Clin Exp Dermatol 1996;21:141-144.
33. Gemke GR, Kaupasa MM, Baldmane NJ: Secondary amyloidosis as possible complication of psoriasis (in Russian). Klin Med Mosk 1997; 75:55-56.
34. Kratz A, Lewandrowski KB: Normal reference laboratory values. N Engl J Med 1998;339: 1069-1072.
35. Zemer D, Livneh A, Langevitz P: Reversal of the nephrotic syndrome by colchicine in amyloidosis of familial Mediterranean fever. Ann Intern Med 1992;116:426.
36. Boyd AS, Menter A: Erythrodermic psoriasis. Precipitating factors, course, and prognosis in 50 patients. J Am Acad Dermatol 1989;21: 985-991.
37. Zachariae H, Grunnet E, Sogaard H: Accidental kidney biopsies in psoriasis. Br J Dermatol 1976;94:655-657.
38. Zacharie H: Pathologic findings in internal organs in psoriasis. Int J Dermatol 1994;33:323-326.
39. Zacharie H, Kragballe K, Hansen HE, Marcussen N, Olsen S: Renal biopsy findings in long-term cyclosporin treatment of psoriasis. Br J Dermatol 1997;136:531-535.
40. Kaftan O, Kaftan B, Toppare MF, Eksioglu M: Renal involvement in psoriasis. Dermatology 1996;192:189-190.
41. Lindelof B, Eklund G, Liden S, Stern RS: The prevalence of malignant tumors in patients with psoriasis. J Am Acad Dermatol 1990;22: 1056-1060.
42. Olsen JH, Moller H, Frentz G: Malignant tumors in patients with psoriasis. J Am Acad Dermatol 1992;27:716-722.
43. Gertz MA, Kyle RA: Amyloidosis: Prognosis and treatment. Semin Arthritis Rheum 1994; 24:124-138.
44. Spuls PI, Witkamp L, Bossuyt PMM, Bos JD: A systemic review of five systemic treatments for severe psoriasis. Br J Dermatol 1997;137: 943-949.
45. Jones G, Crotty M, Brooks P, The Psoriatic Arthritis Meta-Analysis Study Group: Psoriatic arthritis: A quantitative overview of therapeutic options. Br J Rheumatol 1997;36:95-99.
46. Silverman Kitchin JF, Pomeranz MK, Pak G, Waschenik K, Shupack JL: Rediscovering mycophenolic acid: A review of its mechanism, side effects, and potential uses. J Am Acad Dermatol 1997;37:445-449.
47. Kramer P, Brunner FP, Brynger H, Chantler C, Donckerwolcke RA, Jacobs C, Selwood NH, Wing AJ (Registration Committee of the European Dialysis and Transplantation Association): Dialysis treatment and psoriasis in Europe. Clin Nephrol 1982;18:62-68.
48. Meyers S, Janowitz HD, Gumaste VV, Abramsom Rc, Berman LJ, Venkataseshan VS, Dickman SH: Colchicine therapy of the renal amyloidosis of ulcerative colitis. Gastroenterology 1988;94:1503-1507.
49. Escalante A, Ehresmann GR, Quismorio FP Jr: Regression of reactive systemic amyloidosis due to ankylosing spondylitis following the administration of colchicine. Arthritis Rheum 1991;34:920-922.
50. Tarsuta E, Sipe JD, Shirahama T, Skinner M, Cohen AS: Colchicine inhibition of serum amyloid protein SAA and SAP synthesis in primary mouse liver cell cultures. Arthritis Rheum 1984;27:349-352.
51. 1-acid glycoprotein, and fibrinogen. Semin Arthritis Rheum 1990;20:129-147.
52. Brandwein SR, Sipe JD, Skinner M, Cohen AS: Effect of colchicine on experimental amyloidosis on two CBA/J mouse models. Lab Invest 1985;52:319-325.
53. Brandwein SR, Sipe JD, Cohen AS: Combined treatment with terbutaline and aminophylline inhibits experimental amyloidosis in mice. Arthritis Rheum 1994;37:1757-1760.